Abstract
A case report series study for the effects of Policosanol on Post-Stroke Cognitive Impairment
Ischemic stroke may be a leading explanation for disability, including post-stroke cognitive impairment (CI), that no effective therapy is out there. Post-stroke patients are managed with antiplatelet drugs, and antihypertensive, hypoglycemic and/or cholesterol-lowering drugs, as needed. Policosanol is an antiplatelet and cholesterol lowering agent. Studies done before are demonstrated that adding policosanol to aspirin (AS) therapy improves post-stroke neurological recovery compared to placebo + AS.
Author(s): Javier Sanchez, Trujillo C
Warning: Undefined variable $art_rows in /efsdata/imedpub-com/abstract/abstract-page.php on line 110
Warning: Attempt to read property "select_abs_row" on null in /efsdata/imedpub-com/abstract/abstract-page.php on line 110
Abstract | PDF
Share This Article
Awards Nomination
Warning: Attempt to read property "page_url" on null in /efsdata/imedpub-com/bootstrap_journal_right_content.php on line 194
Google Scholar citation report
Abstracted/Indexed in
- Google Scholar
Warning: Attempt to read property "page_url" on null in /efsdata/imedpub-com/bootstrap_journal_right_content.php on line 194
Open Access Journals
- Aquaculture & Veterinary Science
- Chemistry & Chemical Sciences
- Clinical Sciences
- Engineering
- General Science
- Genetics & Molecular Biology
- Health Care & Nursing
- Immunology & Microbiology
- Materials Science
- Mathematics & Physics
- Medical Sciences
- Neurology & Psychiatry
- Oncology & Cancer Science
- Pharmaceutical Sciences